Avoid Ranbaxy Laboratories: Sudarshan Sukhani

Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "Ranbaxy Laboratories is not showing any sign of stability here. So it is now in a no-man's land. It can go wherever it wants, fall further. I would be completely away from it."

At 13:18 hrs Ranbaxy Laboratories was quoting at Rs 353.15, down Rs 12.25, or 3.35 percent.It has touched a 52-week low of Rs 342.75.
The share touched its 52-week high Rs 578.30 and 52-week low Rs 357.20 on 04 September, 2012 and 04 June, 2013, respectively. Currently, it is trading 38.93 percent below its 52-week high and 1.13 percent above its 52-week low. Market capitalisation stands at Rs 14,941.81 crore. Also Read: DIPP to send proposal to PMO on review of pharma FDI policy